The National Technical Advisory Group on Immunisation (NTAGI) is likely to meet soon to discuss inclusion of Covid vaccine Covovax on the CoWIN portal as a heterologous booster dose for adults to boost uptake of booster doses, said official sources.
According to new research published in BMJ Global Health, pregnant women infected with the virus that causes COVID-19 have 7 times increased chance of dying and a considerably increased risk of being admitted to an intensive care unit or suffering from pneumonia. The study also reveals that
The study, which was published on January 13 in the journal Science, identifies a potential target for anti-tick vaccines or therapeutics to prevent the spread of infections like Lyme disease.
"We all appreciate the principle of globalisation. India has always seen the world as one family. Developing countries desire globalisation that does not create a climate crisis, does not lead to unequal vaccine distribution or over-concentrated global supply chains. We want a globalisation
The Central drug regulatory authority Drugs Controller General of India (DCGI) has recommended market authorisation for Serum Institute of India's Covid vaccine Covovax as a heterologous booster dose for those who have already taken two doses of Covishield or Covaxin.
The Health Department of Uttarakhand has successfully completed the trial of drone technology to deliver medicines and vaccines in a time-bound manner.